<--- Back to Details
First PageDocument Content
Food and Drug Administration / Pharmacology / Medical technology / Benign prostatic hyperplasia / Investigational Device Exemption / Prostate / Transurethral microwave thermotherapy / Medical device / Lower urinary tract symptoms / Medicine / Clinical research / Pharmaceutical industry
Food and Drug Administration
Pharmacology
Medical technology
Benign prostatic hyperplasia
Investigational Device Exemption
Prostate
Transurethral microwave thermotherapy
Medical device
Lower urinary tract symptoms
Medicine
Clinical research
Pharmaceutical industry

  Guidance for Industry and   Food and Drug Administration   Staff  Guidance for the Non‐Clinical and 

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 441,58 KB

Share Document on Facebook

Similar Documents

CNE Objectives and Evaluation Form appear on pageSERIES An Overview of Prostate Cancer: Diagnosis and Treatment

CNE Objectives and Evaluation Form appear on pageSERIES An Overview of Prostate Cancer: Diagnosis and Treatment

DocID: 1qs3X - View Document

Prostate Cancer Awareness What Is the Prostate? The prostate is a part of the male reproductive system. The prostate is located just below the bladder and in front of the rectum. It is about the size of a walnut and surr

Prostate Cancer Awareness What Is the Prostate? The prostate is a part of the male reproductive system. The prostate is located just below the bladder and in front of the rectum. It is about the size of a walnut and surr

DocID: 1qiiR - View Document

Effect of craniosacral therapy on lower urinary tract signs and symptoms in multiple sclerosis

Effect of craniosacral therapy on lower urinary tract signs and symptoms in multiple sclerosis

DocID: 1m7Wn - View Document

Sector Processor Status Report Status of Tests − Acosta Schedule − Acosta SP Latency

Sector Processor Status Report Status of Tests − Acosta Schedule − Acosta SP Latency

DocID: 1geww - View Document

Prescription rate of medications potentially contributing to lower urinary tract symptoms and detection of adverse reactions by prescription sequence symmetry analysis

Prescription rate of medications potentially contributing to lower urinary tract symptoms and detection of adverse reactions by prescription sequence symmetry analysis

DocID: 1fS2i - View Document